Persistent Placoid Maculopathy. A New Clinical Entity

Pamela R. Golchet, Lee M. Jampol, David Wilson, Lawrence A. Yannuzzi, Michael Ober, Edward Stroh

Research output: Contribution to journalArticle

26 Citations (Scopus)

Abstract

Purpose: To describe a previously unreported clinical entity superficially resembling macular serpiginous choroiditis but with a distinct presentation and clinical course. Design: Retrospective observational case series. Participants: Six patients, 50 to 68 years old, exhibiting this entity who were seen at 5 different centers from 1984 to 2006. Methods: Review of medical records. Main Outcome Measures: Best-corrected visual acuity (VA) and clinical and angiographic findings. Results: The lesions in our patients are similar to those of acute macular serpiginous choroiditis. Our patients had well-delineated whitish plaquelike lesions involving the macula and sparing the peripapillary areas of both eyes. In contrast to serpiginous choroiditis, VA remained good despite early involvement of the fovea until complications related to choroidal neovascularization or pigmentary mottling developed. Angiographic characteristics and the clinical course were also atypical. Fluorescein angiography revealed well-defined early hypofluorescent areas that partially filled in in the late phase. Indocyanine green angiography showed the hypofluorescence to be persistent. Unlike serpiginous choroiditis, the white macular lesions faded over a period of months to years, whereas the characteristic angiographic findings often persisted longer. Choroidal neovascularization developed in 11 of 12 eyes, with subsequent conversion to disciform macular scars in 9 of 12 eyes. Unlike serpiginous choroiditis, none of the eyes showed chorioretinal scar formation unless related to choroidal neovascularization. Conclusion: Persistent placoid maculopathy has features resembling macular serpiginous choroiditis but differs in its clinical course and effect on VA. It appears to be a new entity. The majority of eyes develop choroidal neovascularization that results in loss of central vision.

Original languageEnglish (US)
Pages (from-to)1530-1540
Number of pages11
JournalOphthalmology
Volume114
Issue number8
DOIs
StatePublished - Aug 2007

Fingerprint

Choroiditis
Choroidal Neovascularization
Visual Acuity
Cicatrix
Indocyanine Green
Fluorescein Angiography
Medical Records
Angiography
Outcome Assessment (Health Care)

ASJC Scopus subject areas

  • Ophthalmology

Cite this

Golchet, P. R., Jampol, L. M., Wilson, D., Yannuzzi, L. A., Ober, M., & Stroh, E. (2007). Persistent Placoid Maculopathy. A New Clinical Entity. Ophthalmology, 114(8), 1530-1540. https://doi.org/10.1016/j.ophtha.2006.10.050

Persistent Placoid Maculopathy. A New Clinical Entity. / Golchet, Pamela R.; Jampol, Lee M.; Wilson, David; Yannuzzi, Lawrence A.; Ober, Michael; Stroh, Edward.

In: Ophthalmology, Vol. 114, No. 8, 08.2007, p. 1530-1540.

Research output: Contribution to journalArticle

Golchet, PR, Jampol, LM, Wilson, D, Yannuzzi, LA, Ober, M & Stroh, E 2007, 'Persistent Placoid Maculopathy. A New Clinical Entity', Ophthalmology, vol. 114, no. 8, pp. 1530-1540. https://doi.org/10.1016/j.ophtha.2006.10.050
Golchet PR, Jampol LM, Wilson D, Yannuzzi LA, Ober M, Stroh E. Persistent Placoid Maculopathy. A New Clinical Entity. Ophthalmology. 2007 Aug;114(8):1530-1540. https://doi.org/10.1016/j.ophtha.2006.10.050
Golchet, Pamela R. ; Jampol, Lee M. ; Wilson, David ; Yannuzzi, Lawrence A. ; Ober, Michael ; Stroh, Edward. / Persistent Placoid Maculopathy. A New Clinical Entity. In: Ophthalmology. 2007 ; Vol. 114, No. 8. pp. 1530-1540.
@article{db0fddb2f1cb4878809a7beea0985a55,
title = "Persistent Placoid Maculopathy. A New Clinical Entity",
abstract = "Purpose: To describe a previously unreported clinical entity superficially resembling macular serpiginous choroiditis but with a distinct presentation and clinical course. Design: Retrospective observational case series. Participants: Six patients, 50 to 68 years old, exhibiting this entity who were seen at 5 different centers from 1984 to 2006. Methods: Review of medical records. Main Outcome Measures: Best-corrected visual acuity (VA) and clinical and angiographic findings. Results: The lesions in our patients are similar to those of acute macular serpiginous choroiditis. Our patients had well-delineated whitish plaquelike lesions involving the macula and sparing the peripapillary areas of both eyes. In contrast to serpiginous choroiditis, VA remained good despite early involvement of the fovea until complications related to choroidal neovascularization or pigmentary mottling developed. Angiographic characteristics and the clinical course were also atypical. Fluorescein angiography revealed well-defined early hypofluorescent areas that partially filled in in the late phase. Indocyanine green angiography showed the hypofluorescence to be persistent. Unlike serpiginous choroiditis, the white macular lesions faded over a period of months to years, whereas the characteristic angiographic findings often persisted longer. Choroidal neovascularization developed in 11 of 12 eyes, with subsequent conversion to disciform macular scars in 9 of 12 eyes. Unlike serpiginous choroiditis, none of the eyes showed chorioretinal scar formation unless related to choroidal neovascularization. Conclusion: Persistent placoid maculopathy has features resembling macular serpiginous choroiditis but differs in its clinical course and effect on VA. It appears to be a new entity. The majority of eyes develop choroidal neovascularization that results in loss of central vision.",
author = "Golchet, {Pamela R.} and Jampol, {Lee M.} and David Wilson and Yannuzzi, {Lawrence A.} and Michael Ober and Edward Stroh",
year = "2007",
month = "8",
doi = "10.1016/j.ophtha.2006.10.050",
language = "English (US)",
volume = "114",
pages = "1530--1540",
journal = "Ophthalmology",
issn = "0161-6420",
publisher = "Elsevier Inc.",
number = "8",

}

TY - JOUR

T1 - Persistent Placoid Maculopathy. A New Clinical Entity

AU - Golchet, Pamela R.

AU - Jampol, Lee M.

AU - Wilson, David

AU - Yannuzzi, Lawrence A.

AU - Ober, Michael

AU - Stroh, Edward

PY - 2007/8

Y1 - 2007/8

N2 - Purpose: To describe a previously unreported clinical entity superficially resembling macular serpiginous choroiditis but with a distinct presentation and clinical course. Design: Retrospective observational case series. Participants: Six patients, 50 to 68 years old, exhibiting this entity who were seen at 5 different centers from 1984 to 2006. Methods: Review of medical records. Main Outcome Measures: Best-corrected visual acuity (VA) and clinical and angiographic findings. Results: The lesions in our patients are similar to those of acute macular serpiginous choroiditis. Our patients had well-delineated whitish plaquelike lesions involving the macula and sparing the peripapillary areas of both eyes. In contrast to serpiginous choroiditis, VA remained good despite early involvement of the fovea until complications related to choroidal neovascularization or pigmentary mottling developed. Angiographic characteristics and the clinical course were also atypical. Fluorescein angiography revealed well-defined early hypofluorescent areas that partially filled in in the late phase. Indocyanine green angiography showed the hypofluorescence to be persistent. Unlike serpiginous choroiditis, the white macular lesions faded over a period of months to years, whereas the characteristic angiographic findings often persisted longer. Choroidal neovascularization developed in 11 of 12 eyes, with subsequent conversion to disciform macular scars in 9 of 12 eyes. Unlike serpiginous choroiditis, none of the eyes showed chorioretinal scar formation unless related to choroidal neovascularization. Conclusion: Persistent placoid maculopathy has features resembling macular serpiginous choroiditis but differs in its clinical course and effect on VA. It appears to be a new entity. The majority of eyes develop choroidal neovascularization that results in loss of central vision.

AB - Purpose: To describe a previously unreported clinical entity superficially resembling macular serpiginous choroiditis but with a distinct presentation and clinical course. Design: Retrospective observational case series. Participants: Six patients, 50 to 68 years old, exhibiting this entity who were seen at 5 different centers from 1984 to 2006. Methods: Review of medical records. Main Outcome Measures: Best-corrected visual acuity (VA) and clinical and angiographic findings. Results: The lesions in our patients are similar to those of acute macular serpiginous choroiditis. Our patients had well-delineated whitish plaquelike lesions involving the macula and sparing the peripapillary areas of both eyes. In contrast to serpiginous choroiditis, VA remained good despite early involvement of the fovea until complications related to choroidal neovascularization or pigmentary mottling developed. Angiographic characteristics and the clinical course were also atypical. Fluorescein angiography revealed well-defined early hypofluorescent areas that partially filled in in the late phase. Indocyanine green angiography showed the hypofluorescence to be persistent. Unlike serpiginous choroiditis, the white macular lesions faded over a period of months to years, whereas the characteristic angiographic findings often persisted longer. Choroidal neovascularization developed in 11 of 12 eyes, with subsequent conversion to disciform macular scars in 9 of 12 eyes. Unlike serpiginous choroiditis, none of the eyes showed chorioretinal scar formation unless related to choroidal neovascularization. Conclusion: Persistent placoid maculopathy has features resembling macular serpiginous choroiditis but differs in its clinical course and effect on VA. It appears to be a new entity. The majority of eyes develop choroidal neovascularization that results in loss of central vision.

UR - http://www.scopus.com/inward/record.url?scp=34547151575&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=34547151575&partnerID=8YFLogxK

U2 - 10.1016/j.ophtha.2006.10.050

DO - 10.1016/j.ophtha.2006.10.050

M3 - Article

C2 - 17678692

AN - SCOPUS:34547151575

VL - 114

SP - 1530

EP - 1540

JO - Ophthalmology

JF - Ophthalmology

SN - 0161-6420

IS - 8

ER -